Evidence map›Paper›PMID 35611846›Full record

ArticleCancer reports (Hoboken, N.J.)2022

Intra-arterial chemoradiotherapy for locally advanced buccal mucosal cancer in an elderly patient with multiple comorbidities: A case report.

Akito Taniguchi, Yutaka Toyomasu, Akinori Takada, Takamitsu Mase, Kazuto Kurohara, Kazuki Omori, Yui Nanpei, Tomoko Kawamura, Hajime Sakuma, Yoshihito Nomoto

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer reports (Hoboken, N.J.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Akito TaniguchiDepartment of Radiology, Mie University Hospital, Tsu, Mie, Japan.
Yutaka ToyomasuDepartment of Radiology, Mie University Hospital, Tsu, Mie, Japan.ORCID 0000-0001-7027-1031
Akinori TakadaDepartment of Radiology, Mie University Hospital, Tsu, Mie, Japan.
Takamitsu MaseDepartment of Radiology, Mie University Hospital, Tsu, Mie, Japan.
Kazuto KuroharaDepartment of Oral and Maxillofacial Surgery, Mie University Hospital, Tsu, Mie, Japan.
Kazuki OmoriDepartment of Radiology, Mie University Hospital, Tsu, Mie, Japan.
Yui NanpeiDepartment of Radiology, Mie University Hospital, Tsu, Mie, Japan.
Tomoko KawamuraDepartment of Radiology, Mie University Hospital, Tsu, Mie, Japan.
Hajime SakumaDepartment of Radiology, Mie University Hospital, Tsu, Mie, Japan.
Yoshihito NomotoDepartment of Radiology, Mie University Hospital, Tsu, Mie, Japan.
Mie University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe management of locally advanced oral cavity squamous cell carcinoma (LA-OCScc) in elderly patients with multiple comorbidities is difficult. CASE: We report the case of an elderly patient with buccal mucosal squamous cell carcinoma as well as chronic renal dysfunction, hepatic cirrhosis, rheumatoid arthritis, and metachronous diffuse large B-cell lymphoma. We performed radiation therapy (a total dose of 70 Gy in 35 fractions) and six cycles of intra-arterial chemotherapy with 40 mg/m

conclusionIntra-arterial chemoradiotherapy may be a good treatment option for LA-OCScc in elderly patients with multiple comorbidities.

Indexed as

Carcinoma, Squamous CellMouth NeoplasmsAgedChemoradiotherapyCisplatinFollow-Up StudiesHumansCisplatinbuccal mucosal cancercisplatincomorbiditiesintra-arterial chemoradiotherapysquamous cell carcinoma

Identifiers

PMID35611846
PMCPMC9458505
OpenAlexW4281478146

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.